Global and United States Insulin API Market Insights, Forecast to 2027

Publisher Name :
Date: 01-Sep-2021
No. of pages: 149
Inquire Before Buying

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.

Market Analysis and Insights: Global and United States Insulin API Market

This report focuses on global and United States Insulin API market.

In 2020, the global Insulin API market size was US$ 1692.5 million and it is expected to reach US$ 2072.2 million by the end of 2027, with a CAGR of 2.9% during 2021-2027. In United States the Insulin API market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Insulin API Scope and Market Size

Insulin API market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Insulin API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Insulin API market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

- Regular Human Insulin

- Insulin Analogue

Segment by Application

- Fast-Acting

- Premix

- Long-Acting

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Novo Nordisk

- Sanofi-Aventis

- Eli Lilly

- Tonghua Dongbao

- Ganlee

- United Laboratory

- Biocon

- Amphastar

- Wockhardt

- Julphar Diabetes

- Torrent Pharma

Global and United States Insulin API Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Insulin API Product Introduction
1.2 Market by Type
1.2.1 Global Insulin API Market Size Growth Rate by Type
1.2.2 Regular Human Insulin
1.2.3 Insulin Analogue
1.3 Market by Application
1.3.1 Global Insulin API Market Size Growth Rate by Application
1.3.2 Fast-Acting
1.3.3 Premix
1.3.4 Long-Acting
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Insulin API Market Size, Estimates and Forecasts
2.1.1 Global Insulin API Revenue 2016-2027
2.1.2 Global Insulin API Sales 2016-2027
2.2 Global Insulin API, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Insulin API Historical Market Size by Region (2016-2021)
2.3.1 Global Insulin API Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Insulin API Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Insulin API Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Insulin API Sales Forecast by Region (2022-2027)
2.4.2 Global Insulin API Revenue Forecast by Region (2022-2027)
3 Global Insulin API Competitor Landscape by Players
3.1 Global Top Insulin API Manufacturers by Sales
3.1.1 Global Insulin API Sales by Manufacturer (2016-2021)
3.1.2 Global Insulin API Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Insulin API Manufacturers by Revenue
3.2.1 Key Insulin API Manufacturers Covered: Ranking by Revenue
3.2.2 Global Insulin API Revenue by Manufacturers (2016-2021)
3.2.3 Global Insulin API Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Insulin API Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Insulin API Revenue in 2020
3.2.6 Global Insulin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Insulin API Price by Manufacturers
3.4 Global Insulin API Manufacturing Base Distribution, Product Types
3.4.1 Insulin API Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Insulin API Product Type
3.4.3 Date of International Manufacturers Enter into Insulin API Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Insulin API Market Size by Type (2016-2021)
4.1.1 Global Insulin API Sales by Type (2016-2021)
4.1.2 Global Insulin API Revenue by Type (2016-2021)
4.1.3 Insulin API Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Insulin API Market Size Forecast by Type (2022-2027)
4.2.1 Global Insulin API Sales Forecast by Type (2022-2027)
4.2.2 Global Insulin API Revenue Forecast by Type (2022-2027)
4.2.3 Insulin API Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Insulin API Market Size by Application (2016-2021)
5.1.1 Global Insulin API Sales by Application (2016-2021)
5.1.2 Global Insulin API Revenue by Application (2016-2021)
5.1.3 Insulin API Price by Application (2016-2021)
5.2 Insulin API Market Size Forecast by Application (2022-2027)
5.2.1 Global Insulin API Sales Forecast by Application (2022-2027)
5.2.2 Global Insulin API Revenue Forecast by Application (2022-2027)
5.2.3 Global Insulin API Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Insulin API Market Size YoY Growth 2016-2027
6.1.1 United States Insulin API Sales YoY Growth 2016-2027
6.1.2 United States Insulin API Revenue YoY Growth 2016-2027
6.1.3 United States Insulin API Market Share in Global Market 2016-2027
6.2 United States Insulin API Market Size by Players (International and Local Players)
6.2.1 United States Top Insulin API Players by Sales (2016-2021)
6.2.2 United States Top Insulin API Players by Revenue (2016-2021)
6.3 United States Insulin API Historic Market Review by Type (2016-2021)
6.3.1 United States Insulin API Sales Market Share by Type (2016-2021)
6.3.2 United States Insulin API Revenue Market Share by Type (2016-2021)
6.3.3 United States Insulin API Price by Type (2016-2021)
6.4 United States Insulin API Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Insulin API Sales Forecast by Type (2022-2027)
6.4.2 United States Insulin API Revenue Forecast by Type (2022-2027)
6.4.3 United States Insulin API Price Forecast by Type (2022-2027)
6.5 United States Insulin API Historic Market Review by Application (2016-2021)
6.5.1 United States Insulin API Sales Market Share by Application (2016-2021)
6.5.2 United States Insulin API Revenue Market Share by Application (2016-2021)
6.5.3 United States Insulin API Price by Application (2016-2021)
6.6 United States Insulin API Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Insulin API Sales Forecast by Application (2022-2027)
6.6.2 United States Insulin API Revenue Forecast by Application (2022-2027)
6.6.3 United States Insulin API Price Forecast by Application (2022-2027)
7 North America
7.1 North America Insulin API Market Size YoY Growth 2016-2027
7.2 North America Insulin API Market Facts & Figures by Country
7.2.1 North America Insulin API Sales by Country (2016-2021)
7.2.2 North America Insulin API Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Insulin API Market Size YoY Growth 2016-2027
8.2 Asia Pacific Insulin API Market Facts & Figures by Region
8.2.1 Asia Pacific Insulin API Sales by Region (2016-2021)
8.2.2 Asia Pacific Insulin API Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Insulin API Market Size YoY Growth 2016-2027
9.2 Europe Insulin API Market Facts & Figures by Country
9.2.1 Europe Insulin API Sales by Country (2016-2021)
9.2.2 Europe Insulin API Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Insulin API Market Size YoY Growth 2016-2027
10.2 Latin America Insulin API Market Facts & Figures by Country
10.2.1 Latin America Insulin API Sales by Country (2016-2021)
10.2.2 Latin America Insulin API Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Insulin API Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Insulin API Market Facts & Figures by Country
11.2.1 Middle East and Africa Insulin API Sales by Country (2016-2021)
11.2.2 Middle East and Africa Insulin API Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Novo Nordisk
12.1.1 Novo Nordisk Corporation Information
12.1.2 Novo Nordisk Description and Business Overview
12.1.3 Novo Nordisk Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novo Nordisk Insulin API Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 Sanofi-Aventis
12.2.1 Sanofi-Aventis Corporation Information
12.2.2 Sanofi-Aventis Description and Business Overview
12.2.3 Sanofi-Aventis Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi-Aventis Insulin API Products Offered
12.2.5 Sanofi-Aventis Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Corporation Information
12.3.2 Eli Lilly Description and Business Overview
12.3.3 Eli Lilly Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Eli Lilly Insulin API Products Offered
12.3.5 Eli Lilly Recent Development
12.4 Tonghua Dongbao
12.4.1 Tonghua Dongbao Corporation Information
12.4.2 Tonghua Dongbao Description and Business Overview
12.4.3 Tonghua Dongbao Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Tonghua Dongbao Insulin API Products Offered
12.4.5 Tonghua Dongbao Recent Development
12.5 Ganlee
12.5.1 Ganlee Corporation Information
12.5.2 Ganlee Description and Business Overview
12.5.3 Ganlee Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Ganlee Insulin API Products Offered
12.5.5 Ganlee Recent Development
12.6 United Laboratory
12.6.1 United Laboratory Corporation Information
12.6.2 United Laboratory Description and Business Overview
12.6.3 United Laboratory Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.6.4 United Laboratory Insulin API Products Offered
12.6.5 United Laboratory Recent Development
12.7 Biocon
12.7.1 Biocon Corporation Information
12.7.2 Biocon Description and Business Overview
12.7.3 Biocon Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Biocon Insulin API Products Offered
12.7.5 Biocon Recent Development
12.8 Amphastar
12.8.1 Amphastar Corporation Information
12.8.2 Amphastar Description and Business Overview
12.8.3 Amphastar Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Amphastar Insulin API Products Offered
12.8.5 Amphastar Recent Development
12.9 Wockhardt
12.9.1 Wockhardt Corporation Information
12.9.2 Wockhardt Description and Business Overview
12.9.3 Wockhardt Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Wockhardt Insulin API Products Offered
12.9.5 Wockhardt Recent Development
12.10 Julphar Diabetes
12.10.1 Julphar Diabetes Corporation Information
12.10.2 Julphar Diabetes Description and Business Overview
12.10.3 Julphar Diabetes Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Julphar Diabetes Insulin API Products Offered
12.10.5 Julphar Diabetes Recent Development
12.11 Novo Nordisk
12.11.1 Novo Nordisk Corporation Information
12.11.2 Novo Nordisk Description and Business Overview
12.11.3 Novo Nordisk Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novo Nordisk Insulin API Products Offered
12.11.5 Novo Nordisk Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Insulin API Industry Trends
13.2 Insulin API Market Drivers
13.3 Insulin API Market Challenges
13.4 Insulin API Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Insulin API Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Insulin API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Regular Human Insulin
Table 3. Major Manufacturers of Insulin Analogue
Table 4. Global Insulin API Market Size Growth Rate by Application (2021-2027) & (Kg)
Table 5. Global Insulin API Market Size by Region (Kg) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Insulin API Sales by Regions (2016-2021) & (Kg)
Table 7. Global Insulin API Sales Market Share by Regions (2016-2021)
Table 8. Global Insulin API Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Insulin API Sales Forecast by Region (2022-2027) & (Kg)
Table 10. Global Insulin API Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Insulin API Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Insulin API Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Insulin API Sales by Manufacturers (2016-2021) (Kg)
Table 14. Global Insulin API Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Insulin API Manufacturers by Revenue (US$ Million) in 2020
Table 16. Insulin API Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Insulin API Revenue Share by Manufacturers (2016-2021)
Table 18. Global Insulin API Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Insulin API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin API as of 2020)
Table 20. Key Manufacturers Insulin API Price (2016-2021) (K US$/Kg)
Table 21. Insulin API Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Insulin API Product Type
Table 23. Date of International Manufacturers Enter into Insulin API Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Insulin API Sales by Type (2016-2021) (Kg)
Table 26. Global Insulin API Sales Share by Type (2016-2021)
Table 27. Global Insulin API Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Insulin API Revenue Share by Type (2016-2021)
Table 29. Insulin API Average Selling Price (ASP) by Type (2016-2021) & (K US$/Kg)
Table 30. Global Insulin API Sales Forecast by Type (2022-2027) & (Kg)
Table 31. Global Insulin API Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Insulin API Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Insulin API Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Insulin API Average Selling Price (ASP) Forecast by Type (2022-2027) & (K US$/Kg)
Table 35. Global Insulin API Sales by Application (2016-2021) (Kg)
Table 36. Global Insulin API Sales Share by Application (2016-2021)
Table 37. Global Insulin API Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Insulin API Revenue Share by Application (2016-2021)
Table 39. Insulin API Average Selling Price (ASP) by Application (2016-2021) & (K US$/Kg)
Table 40. Global Insulin API Sales Forecast by Application (2022-2027) & (Kg)
Table 41. Global Insulin API Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Insulin API Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Insulin API Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Insulin API Average Selling Price (ASP) Forecast by Application (2022-2027) & (K US$/Kg)
Table 45. United States Insulin API Sales (Kg) of Key Companies (2016-2021)
Table 46. United States Insulin API Sales Share by Company (2016-2021)
Table 47. United States Insulin API Revenue (US$ Million) by Company (2016-2021)
Table 48. United States Insulin API Revenue Share by Company (2016-2021)
Table 49. United States Insulin API Sales (Kg) by Type (2016-2021)
Table 50. United States Insulin API Sales Share by Type (2016-2021)
Table 51. United States Insulin API Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. United States Insulin API Price (K US$/Kg) by Type (2016-2021)
Table 53. United States Insulin API Sales (Kg) by Type (2022-2027)
Table 54. United States Insulin API Sales Share by Type (2022-2027)
Table 55. United States Insulin API Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. United States Insulin API Revenue Share by Type (2022-2027)
Table 57. United States Insulin API Price (K US$/Kg) by Type (2022-2027)
Table 58. United States Insulin API Sales (Kg) by Application (2016-2021)
Table 59. United States Insulin API Sales Share by Application (2016-2021)
Table 60. United States Insulin API Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. United States Insulin API Price (K US$/Kg) by Application (2016-2021)
Table 62. United States Insulin API Sales (Kg) by Application (2022-2027)
Table 63. United States Insulin API Sales Share by Application (2022-2027)
Table 64. United States Insulin API Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. United States Insulin API Revenue Share by Application (2022-2027)
Table 66. United States Insulin API Price (K US$/Kg) by Application (2022-2027)
Table 67. North America Insulin API Sales by Country (2016-2021) & (Kg)
Table 68. North America Insulin API Sales Market Share by Country (2016-2021)
Table 69. North America Insulin API Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Insulin API Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Insulin API Sales by Region (2016-2021) & (Kg)
Table 72. Asia Pacific Insulin API Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Insulin API Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Insulin API Revenue Market Share by Region (2016-2021)
Table 75. Europe Insulin API Sales by Country (2016-2021) & (Kg)
Table 76. Europe Insulin API Sales Market Share by Country (2016-2021)
Table 77. Europe Insulin API Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Insulin API Revenue Market Share by Country (2016-2021)
Table 79. Latin America Insulin API Sales by Country (2016-2021) & (Kg)
Table 80. Latin America Insulin API Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Insulin API Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Insulin API Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Insulin API Sales by Country (2016-2021) & (Kg)
Table 84. Middle East and Africa Insulin API Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Insulin API Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Insulin API Revenue Market Share by Country (2016-2021)
Table 87. Novo Nordisk Corporation Information
Table 88. Novo Nordisk Description and Business Overview
Table 89. Novo Nordisk Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2016-2021)
Table 90. Novo Nordisk Insulin API Product
Table 91. Novo Nordisk Recent Development
Table 92. Sanofi-Aventis Corporation Information
Table 93. Sanofi-Aventis Description and Business Overview
Table 94. Sanofi-Aventis Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2016-2021)
Table 95. Sanofi-Aventis Product
Table 96. Sanofi-Aventis Recent Development
Table 97. Eli Lilly Corporation Information
Table 98. Eli Lilly Description and Business Overview
Table 99. Eli Lilly Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2016-2021)
Table 100. Eli Lilly Product
Table 101. Eli Lilly Recent Development
Table 102. Tonghua Dongbao Corporation Information
Table 103. Tonghua Dongbao Description and Business Overview
Table 104. Tonghua Dongbao Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2016-2021)
Table 105. Tonghua Dongbao Product
Table 106. Tonghua Dongbao Recent Development
Table 107. Ganlee Corporation Information
Table 108. Ganlee Description and Business Overview
Table 109. Ganlee Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2016-2021)
Table 110. Ganlee Product
Table 111. Ganlee Recent Development
Table 112. United Laboratory Corporation Information
Table 113. United Laboratory Description and Business Overview
Table 114. United Laboratory Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2016-2021)
Table 115. United Laboratory Product
Table 116. United Laboratory Recent Development
Table 117. Biocon Corporation Information
Table 118. Biocon Description and Business Overview
Table 119. Biocon Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2016-2021)
Table 120. Biocon Product
Table 121. Biocon Recent Development
Table 122. Amphastar Corporation Information
Table 123. Amphastar Description and Business Overview
Table 124. Amphastar Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2016-2021)
Table 125. Amphastar Product
Table 126. Amphastar Recent Development
Table 127. Wockhardt Corporation Information
Table 128. Wockhardt Description and Business Overview
Table 129. Wockhardt Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2016-2021)
Table 130. Wockhardt Product
Table 131. Wockhardt Recent Development
Table 132. Julphar Diabetes Corporation Information
Table 133. Julphar Diabetes Description and Business Overview
Table 134. Julphar Diabetes Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2016-2021)
Table 135. Julphar Diabetes Product
Table 136. Julphar Diabetes Recent Development
Table 137. Torrent Pharma Corporation Information
Table 138. Torrent Pharma Description and Business Overview
Table 139. Torrent Pharma Insulin API Sales (Kg), Revenue (US$ Million), Price (K US$/Kg) and Gross Margin (2016-2021)
Table 140. Torrent Pharma Product
Table 141. Torrent Pharma Recent Development
Table 142. Insulin API Market Trends
Table 143. Insulin API Market Drivers
Table 144. Insulin API Market Challenges
Table 145. Insulin API Market Restraints
Table 146. Insulin API Customers List
Table 147. Insulin API Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin API Product Picture
Figure 2. Global Insulin API Sales Market Share by Type in 2020 & 2027
Figure 3. Regular Human Insulin Product Picture
Figure 4. Insulin Analogue Product Picture
Figure 5. Global Insulin API Sales Market Share by Application in 2020 & 2027
Figure 6. Fast-Acting
Figure 7. Premix
Figure 8. Long-Acting
Figure 9. Insulin API Report Years Considered
Figure 10. Global Insulin API Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Insulin API Market Size 2016-2027 (US$ Million)
Figure 12. Global Insulin API Sales 2016-2027 (Kg)
Figure 13. Global Insulin API Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Insulin API Sales Market Share by Region (2016-2021)
Figure 15. Global Insulin API Sales Market Share by Region in 2020
Figure 16. Global Insulin API Revenue Market Share by Region (2016-2021)
Figure 17. Global Insulin API Revenue Market Share by Region in 2020
Figure 18. Global Insulin API Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Insulin API Revenue in 2020
Figure 20. Insulin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Insulin API Sales Market Share by Type (2016-2021)
Figure 22. Global Insulin API Sales Market Share by Type in 2020
Figure 23. Global Insulin API Revenue Market Share by Type (2016-2021)
Figure 24. Global Insulin API Revenue Market Share by Type in 2020
Figure 25. Global Insulin API Sales Market Share by Application (2016-2021)
Figure 26. Global Insulin API Sales Market Share by Application in 2020
Figure 27. Global Insulin API Revenue Market Share by Application (2016-2021)
Figure 28. Global Insulin API Revenue Market Share by Application in 2020
Figure 29. United States Insulin API Sales Growth Rate 2016-2027 (Kg)
Figure 30. United States Insulin API Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. United States Insulin API Market Share in Global Market 2016-2027
Figure 32. United States 5 and 10 Largest Insulin API Players Market Share by Revenue in Insulin API in 2020
Figure 33. United States Insulin API Revenue Share by Type (2016-2021)
Figure 34. United States Insulin API Revenue Growth Rate by Type in 2016 & 2020
Figure 35. United States Insulin API Revenue Share by Application (2016-2021)
Figure 36. United States Insulin API Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Insulin API Sales Growth Rate 2016-2021 (Kg)
Figure 38. North America Insulin API Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Insulin API Sales Market Share by Country in 2020
Figure 40. North America Insulin API Revenue Market Share by Country in 2020
Figure 41. U.S. Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 42. U.S. Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 44. Canada Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Insulin API Sales Growth Rate 2016-2021 (Kg)
Figure 46. Europe Insulin API Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Insulin API Sales Market Share by Country in 2020
Figure 48. Europe Insulin API Revenue Market Share by Country in 2020
Figure 49. Germany Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 50. Germany Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 52. France Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 54. U.K. Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 56. Italy Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 58. Russia Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Insulin API Sales Growth Rate 2016-2021 (Kg)
Figure 60. Asia Pacific Insulin API Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Insulin API Sales Market Share by Region in 2020
Figure 62. Asia Pacific Insulin API Revenue Market Share by Region in 2020
Figure 63. China Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 64. China Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 66. Japan Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 68. South Korea Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 70. India Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 72. Australia Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 74. China Taiwan Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 76. Indonesia Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 78. Thailand Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 80. Malaysia Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Latin America Insulin API Sales Growth Rate 2016-2021 (Kg)
Figure 82. Latin America Insulin API Revenue Growth Rate 2016-2021 (US$ Million)
Figure 83. Latin America Insulin API Sales Market Share by Country in 2020
Figure 84. Latin America Insulin API Revenue Market Share by Country in 2020
Figure 85. Mexico Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 86. Mexico Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Brazil Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 88. Brazil Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Argentina Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 90. Argentina Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Middle East and Africa Insulin API Sales Growth Rate 2016-2021 (Kg)
Figure 92. Middle East and Africa Insulin API Revenue Growth Rate 2016-2021 (US$ Million)
Figure 93. Middle East and Africa Insulin API Sales Market Share by Country in 2020
Figure 94. Middle East and Africa Insulin API Revenue Market Share by Country in 2020
Figure 95. Turkey Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 96. Turkey Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Saudi Arabia Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 98. Saudi Arabia Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. UAE Insulin API Sales Growth Rate (2016-2021) (Kg)
Figure 100. UAE Insulin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Insulin API Value Chain
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed
  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs